×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ADPT – adaptive biotechnologies corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ADPT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/26
09:24 am
adpt
Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle [Seeking Alpha]
Low
Report
Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle [Seeking Alpha]
12/15
08:10 am
adpt
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer [Yahoo! Finance]
Low
Report
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer [Yahoo! Finance]
12/15
08:00 am
adpt
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
Low
Report
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
12/9
05:53 pm
adpt
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease [Yahoo! Finance]
Medium
Report
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease [Yahoo! Finance]
12/9
05:07 pm
adpt
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
Medium
Report
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
12/6
08:30 am
adpt
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Low
Report
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
12/3
10:26 pm
adpt
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback [Yahoo! Finance]
Low
Report
Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback [Yahoo! Finance]
12/1
06:03 pm
adpt
Adaptive Biotechnologies (NASDAQ:ADPT) was given a new $21.00 price target on by analysts at Morgan Stanley.
Low
Report
Adaptive Biotechnologies (NASDAQ:ADPT) was given a new $21.00 price target on by analysts at Morgan Stanley.
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
04:05 pm
adpt
adaptive biotechnologies corporation
BEAT
Report
-11.5%
adaptive biotechnologies corporation
8/5/2025
04:05 pm
adpt
adaptive biotechnologies corporation
BEAT
Report
5.8%
adaptive biotechnologies corporation
5/1/2025
04:05 pm
adpt
adaptive biotechnologies corporation
BEAT
Report
33.7%
adaptive biotechnologies corporation
2/11/2025
04:05 pm
adpt
adaptive biotechnologies corporation
BEAT
Report
-0.9%
adaptive biotechnologies corporation
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
07:07 pm
adpt
Form 4 Adaptive Biotechnologies For: Dec 15 Filed by: LO FRANCIS
Low
Report
Form 4 Adaptive Biotechnologies For: Dec 15 Filed by: LO FRANCIS
12/15
04:24 pm
adpt
Form 144 Adaptive Biotechnologies Filed by: LO FRANCIS
Low
Report
Form 144 Adaptive Biotechnologies Filed by: LO FRANCIS
12/12
07:11 pm
adpt
Form 4 Adaptive Biotechnologies For: Dec 10 Filed by: HERSHBERG ROBERT
Low
Report
Form 4 Adaptive Biotechnologies For: Dec 10 Filed by: HERSHBERG ROBERT
12/10
04:03 pm
adpt
Form 144 Adaptive Biotechnologies Filed by: HERSHBERG ROBERT
Low
Report
Form 144 Adaptive Biotechnologies Filed by: HERSHBERG ROBERT
12/8
08:01 pm
adpt
Form 4 Adaptive Biotechnologies For: Dec 04 Filed by: BENZENO SHARON
Low
Report
Form 4 Adaptive Biotechnologies For: Dec 04 Filed by: BENZENO SHARON
12/5
06:31 pm
adpt
Form 4 Adaptive Biotechnologies For: Dec 03 Filed by: ROBINS HARLAN S
Low
Report
Form 4 Adaptive Biotechnologies For: Dec 03 Filed by: ROBINS HARLAN S
12/4
05:16 pm
adpt
Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S
High
Report
Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S
12/4
04:38 pm
adpt
Form 144 Adaptive Biotechnologies Filed by: BENZENO SHARON
High
Report
Form 144 Adaptive Biotechnologies Filed by: BENZENO SHARON
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/27
Form 424B4 Adaptive Biotechnologies
17.2%
1/23 Adaptive Announces Pricing of Public Offering of Common Stock 13.8%
8/13 Adaptive Biotechnologies stock tumbles after first earnings report since IPO [CNBC] 12.2%
12/4 Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients 8.7%
4/18 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $46.00 price target on the stock. 7.4%
11/1 Illumina's Next Big Move: Distributed Diagnostics [The Motley Fool] 6.8%
6/27 Adaptive Biotech and BridgeBio shares rocket higher on their first day of trade [MarketWatch] 6.3%
8/7 Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub 5.7%
11/15 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $36.00 price target on the stock. 5.4%
1/7 Form 4 Adaptive Biotechnologies For: Jan 06 Filed by: HILL NANCY LOUISE 5.3%
1/23 Adaptive Announces Pricing of Public Offering of Common Stock 13.8%
8/13 Adaptive Biotechnologies stock tumbles after first earnings report since IPO [CNBC] 12.2%
12/4 Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients 8.7%
4/18 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $46.00 price target on the stock. 7.4%
11/1 Illumina's Next Big Move: Distributed Diagnostics [The Motley Fool] 6.8%
6/27 Adaptive Biotech and BridgeBio shares rocket higher on their first day of trade [MarketWatch] 6.3%
8/7 Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub 5.7%
11/15 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $36.00 price target on the stock. 5.4%
1/7 Form 4 Adaptive Biotechnologies For: Jan 06 Filed by: HILL NANCY LOUISE 5.3%
TOP News Decliners
3/11
Form 4 Adaptive Biotechnologies For: Mar 09 Filed by: Cohen Chad M
-17.8%
11/12 Form 10-Q Adaptive Biotechnologies For: Sep 30 -11.7%
4/2 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -9.8%
1/15 Adaptive Biotechnologies (ADPT) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow [Seeking Alpha] -8.3%
2/26 Form 8-K Adaptive Biotechnologies For: Feb 26 -7.8%
9/23 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $45.00 price target on the stock. -7.1%
9/24 Form 8-K Adaptive Biotechnologies For: Sep 24 -6.4%
4/22 Form 4 Adaptive Biotechnologies For: Apr 20 Filed by: ROBINS HARLAN S -5.9%
8/2 Form 8-K Adaptive Biotechnologies For: Jul 31 -5.9%
1/17 Form 4 Adaptive Biotechnologies For: Jan 15 Filed by: ROBINS HARLAN S -4.3%
11/12 Form 10-Q Adaptive Biotechnologies For: Sep 30 -11.7%
4/2 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -9.8%
1/15 Adaptive Biotechnologies (ADPT) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow [Seeking Alpha] -8.3%
2/26 Form 8-K Adaptive Biotechnologies For: Feb 26 -7.8%
9/23 Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $45.00 price target on the stock. -7.1%
9/24 Form 8-K Adaptive Biotechnologies For: Sep 24 -6.4%
4/22 Form 4 Adaptive Biotechnologies For: Apr 20 Filed by: ROBINS HARLAN S -5.9%
8/2 Form 8-K Adaptive Biotechnologies For: Jul 31 -5.9%
1/17 Form 4 Adaptive Biotechnologies For: Jan 15 Filed by: ROBINS HARLAN S -4.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: